BioNexus Gene Lab Corp.(BGLC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BGLC BioNexus Gene Lab Corp.

Trading 04-09 10:39:06 EDT

2.28

-0.35

-13.50%

High2.84	Low2.25	Vol62.28K
Open2.65	D1 Closing2.63	Amplitude22.24%
Mkt Cap4.09M	Tradable Cap2.80M	Total Shares1.80M
T/O164.59K	T/O Rate5.06%	Tradable Shares1.23M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"BGLC","market":"US","secType":"STK","nameCN":"BioNexus Gene Lab Corp.","latestPrice":2.275,"timestamp":1744209521499,"preClose":2.63,"halted":0,"volume":62281,"delay":0,"floatShares":1230720,"shares":1796760,"eps":-0.53005,"marketStatus":"Trading","change":-0.355,"latestTime":"04-09 10:39:06 EDT","open":2.65,"high":2.835,"low":2.25,"amount":164585.701311,"amplitude":0.222433,"askPrice":2.3,"askSize":1500,"bidPrice":2.22,"bidSize":103,"shortable":0,"etf":0,"ttmEps":-0.53005,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1744228800000},"marketStatusCode":2,"adr":0,"listingDate":1689825600000,"exchange":"NASDAQ","adjPreClose":2.63,"preHourTrading":{"tag":"盘前","latestPrice":2.85,"preClose":2.63,"latestTime":"09:19 EDT","volume":3456,"amount":9614.327616,"timestamp":1744204766741},"postHourTrading":{"tag":"盘后","latestPrice":2.77,"preClose":2.63,"latestTime":"19:59 EDT","volume":9352,"amount":25285.606,"timestamp":1744156798130},"volumeRatio":1.843981},"requestUrl":"/m/hq/s/BGLC","defaultTab":"news","newsList":[{"id":"2524775552","title":"US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert","url":"https://stock-news.laohu8.com/highlight/detail?id=2524775552","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524775552?lang=en_us&edition=full_marsco","pubTime":"2025-04-04 18:18","pubTimestamp":1743761920,"startTime":"0","endTime":"0","summary":"U.S. stock futures continued to decline on Friday after a bloodbath on Thursday following the introduction of Donald Trump&#39;s tariffs.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ed34882fb9ddc686c1c3545b5bf10cfd","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44643100/us-stocks-likely-to-open-lower-after-the-worst-selloff-since-2020-tariff-announcement-was-100-smoot-hawley-disguised-as-thoughtful-policy-says-expert","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","SQQQ","NVDD","NMTC","AAPL","SPXU","CXAI",".IXIC","QID","NQmain","NVD2.UK","USJW.SI","VOO","SDS","NVDU","NVDX","NVDS","OEX","QQQ","SNVD.UK","2NVD.UK","ESmain",".SPX","MULN","NVDY","NVIW.SI","SPY","OEF","PSQ","QLD","TQQQ","NVD3.UK","SGMO","MACW.SI","SH","USAW.SI","SSO","3NVD.UK","BGLC","NVDS.UK","SLP","NVD","LW","AMS"],"gpt_icon":1},{"id":"2517537844","title":"BioNexus Gene Partners With ML Tech for Treasury Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517537844","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517537844?lang=en_us&edition=full_marsco","pubTime":"2025-03-08 01:09","pubTimestamp":1741367342,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab  said it is partnering with ML Tech to optimize its Ethereum-focused treasury strategy.The company said it plans to leverage ML Tech's digital asset trading infrastructure to grow its Ethereum holdings. ML Tech is a wealth management platform for digital assets.Shares of the company were up over 3% in recent trading.Price: 0.36, Change: +0.01, Percent Change: +3.77","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDO.USD.HKCC","US6M.BOND","09179","CETH","03046","FETH","US10Y.BOND","US2Y.BOND","US7Y.BOND","BK4104","STRK","BGLC","09009","BK4516","BK4585","BK4166","ETHV","ETH.USD.HKCC","BK4595","BK4588","BK4596","ML","03179","03009","ETH.USD.CC","EZET","US12M.BOND","US5Y.BOND","US3Y.BOND","BK1611","US30Y.BOND","BK4600","BK4601","BK4023","09046","QETH"],"gpt_icon":0},{"id":"2517458165","title":"Bionexus Gene Lab enters partnership with ML Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458165","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517458165?lang=en_us&edition=full_marsco","pubTime":"2025-03-08 00:10","pubTimestamp":1741363852,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth strategies. Through this partn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bionexus-gene-lab-enters-partnership-with-ml-tech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bionexus-gene-lab-enters-partnership-with-ml-tech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4166","BK4104","ETHV","QETH","CETH","FETH","ML","BGLC","BK4601","EZET"],"gpt_icon":0},{"id":"2517308714","title":"BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517308714","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517308714?lang=en_us&edition=full_marsco","pubTime":"2025-03-08 00:00","pubTimestamp":1741363200,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia, March  08, 2025  (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/07/3039065/0/en/BioNexus-Gene-Lab-Corp-and-ML-Tech-Partner-to-Enhance-Ethereum-focused-Treasury-Strategy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BGLC","BK4104","CETH","BK4601","09009","BK1611","BK4166","03179","STRK","BK4596","BK4023","BK4585","FETH","ETHV","QETH","ML","BK4595","EZET","09179","BK4600","03009","03046","BK4516","09046"],"gpt_icon":1},{"id":"2517537831","title":"BioNexus Gene Lab Becomes First Nasdaq-Listed Company to Embrace Ethereum as Treasury Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2517537831","media":"BE[IN]CRYPTO","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517537831?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 18:34","pubTimestamp":1741257292,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab becomes the first Nasdaq-listed company to adopt Ethereum as its primary treasury asset.Ethereum’s versatility, high liquidity, and Proof-of-Stake rewards make it ideal for corporate treasury, according to BioNexus.Despite recent market declines, BioNexus is confident in Ethereum’s long-term potential, citing institutional adoption and scalability.BioNexus Gene Lab Corp, a Wyoming-based healthcare technology company, has become the first Nasdaq-listed company to adopt Ethereum  as its primary treasury asset.The announcement was made on March 5. It was accompanied by the release of a strategic whitepaper detailing the company’s rationale for prioritizing Ethereum over Bitcoin .The board-approved Ethereum treasury strategy positions BioNexus at the forefront of a growing trend of corporations integrating digital assets into their financial frameworks.Unlike Bitcoin, often hailed as a digital “store of value,” BioNexus is betting on Ethereum’s versatility as a programmab","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/03/bic_ETH_Ethereum_Staking-covers_safe-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/03/bic_ETH_Ethereum_Staking-covers_safe-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/bionexus-ethereum-treasury-strategy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BGLC","BK4601","ETHV","TQQQ","QID","IE00B64PRP62.GBP","NVIW.SI","NQmain","PSQ","ETH.USD.HKCC",".IXIC","SQQQ","BTC","USAW.SI","ETHE","BTC.USD.CC","BK4585","MNQmain","LU2210150020.SGD","USJW.SI","ETH","FETH","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","ETH.USD.CC","IE00B3QW5Z07.USD","LDO.USD.HKCC","QETH","BK4112","EZET","CETH","LU2095319765.USD","TSYW.SI","NDAQ","BTC.USD.HKCC","QLD","IE00BGHQF748.EUR"],"gpt_icon":1},{"id":"2517918704","title":"BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq To Do So","url":"https://stock-news.laohu8.com/highlight/detail?id=2517918704","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517918704?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 15:37","pubTimestamp":1741246627,"startTime":"0","endTime":"0","summary":"Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as a treasury reserve asset on Wednesday, following the cryptocurrency’s inclusion in th","market":"us","thumbnail":"https://www.benzinga.com/files/images/story/2025/03/06/Trump-Backed-World-Liberty-Financial-Bag.jpeg","type":0,"news_type":0,"thumbnails":["https://www.benzinga.com/files/images/story/2025/03/06/Trump-Backed-World-Liberty-Financial-Bag.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/03/44159709/bionexus-shares-surge-after-company-claims-to-be-the-first-on-nasdaq-with-an-ethereum-focused-treasury-strategy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"Benzinga","symbols":["BK4594","TSYW.SI","BTC.USD.HKCC","USAW.SI","USJW.SI","BK4112","ETH","IE00B64PRP62.GBP","ETH.USD.CC","NQmain","LU2095319765.USD","BK4104","BK4601",".IXIC","TQQQ","IE00BKPKM429.USD","QLD","FETH","LDO.USD.HKCC","IE00B3QW5Z07.USD","CETH","LU2210149790.SGD","NVIW.SI","ETHV","BK4585","IE00BGHQF748.EUR","SQQQ","LU2210150020.SGD","QID","MNQmain","QETH","BK4588","NDAQ","PSQ","BGLC","ETH.USD.HKCC","EZET","BTC.USD.CC"],"gpt_icon":1},{"id":"2517312947","title":"BioNexus Gene Reports Approval of Ethereum Treasury Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517312947","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517312947?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 01:34","pubTimestamp":1741196053,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab  said Wednesday its board has approved its Ethereum-focused treasury strategy, prioritizing Ethereum as a strategic treasury asset.The company said Ethereum presents a strategic treasury management solution due partly to its institutional credibility and yield-generation capabilities.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDO.USD.HKCC","US6M.BOND","09179","CETH","03046","FETH","US10Y.BOND","US2Y.BOND","US7Y.BOND","BK4104","STRK","BGLC","09009","BK4516","BK4585","ETHV","ETH.USD.HKCC","BK4595","BK4588","BK4596","03179","03009","ETH.USD.CC","EZET","US12M.BOND","US5Y.BOND","US3Y.BOND","BK1611","US30Y.BOND","BK4600","BK4601","BK4023","09046","QETH"],"gpt_icon":0},{"id":"2517448249","title":"BRIEF-Bionexus Gene Lab Corp Announces Board Approval Of Ethereum Treasury Strategy And Release Of Strategic Whitepaper","url":"https://stock-news.laohu8.com/highlight/detail?id=2517448249","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517448249?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 00:43","pubTimestamp":1741193015,"startTime":"0","endTime":"0","summary":"BRIEF-Bionexus Gene Lab Corp Announces Board Approval Of Ethereum Treasury Strategy And Release Of Strategic WhitepaperMarch 5 (Reuters) - BioNexus Gene Lab Corp BGLC.O:BIONEXUS GENE LAB CORP. ANNOUNC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUABVSSWR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"gpt_icon":0},{"id":"2517863941","title":"Bionexus Gene Lab announces board approval of Ethereum treasury strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517863941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517863941?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 00:11","pubTimestamp":1741191062,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab’s (BGLC) Board of Directors has formally approved the Company’s new Ethereum ($ETH)-focused treasury strategy. Concurrently, BGLC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bionexus-gene-lab-announces-board-approval-of-ethereum-treasury-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bionexus-gene-lab-announces-board-approval-of-ethereum-treasury-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US12M.BOND","US3Y.BOND","US30Y.BOND","BK4104","US2Y.BOND","US6M.BOND","US7Y.BOND","US5Y.BOND","QETH","BK4601","BGLC","US10Y.BOND","ETHV","CETH","ETH","FETH","EZET"],"gpt_icon":0},{"id":"2517498409","title":"BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper","url":"https://stock-news.laohu8.com/highlight/detail?id=2517498409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517498409?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 00:00","pubTimestamp":1741190443,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUABVSSWR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","BGLC"],"gpt_icon":0},{"id":"2517994910","title":"BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper","url":"https://stock-news.laohu8.com/highlight/detail?id=2517994910","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517994910?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 00:00","pubTimestamp":1741190400,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia, March  06, 2025  (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/05/3037582/0/en/BioNexus-Gene-Lab-Corp-Announces-Board-Approval-of-Ethereum-Treasury-Strategy-and-Release-of-Strategic-Whitepaper.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETHV","BK4600","09009","BK1611","03179","ETH","CETH","09179","BK4588","09046","EZET","BK4516","BK4585","03009","BK4023","FETH","BGLC","BK4601","03046","BK4104","BK4596","QETH","STRK","BK4595"],"gpt_icon":1},{"id":"2500970046","title":"BioNexus Gene Lab Given Until May 1 to Regain Nasdaq Compliance; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2500970046","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500970046?lang=en_us&edition=full_marsco","pubTime":"2025-01-03 02:26","pubTimestamp":1735842410,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab  shares were up more than 170% in recent Thursday trading after the company disclosed that it was granted temporary exception until May 1 to regain compliance with the Nasdaq minimum bid price rule.The company said in a regulatory filing Thursday that it plans to implement a reverse stock split, if needed, by April 7, to comply with the listing rule.Additionally, the company said Nasdaq's updated rules for reverse stock splits beginning Jan. 30 require the company to provide details, including shareholder approval, at least 10 days before the reverse stock split's market effective date, according to the filing.Price: 0.76, Change: +0.48, Percent Change: +170.68","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","BK4588","IE00BKPKM429.USD","IE00BGHQF748.EUR",".IXIC","IE00B64PRP62.GBP","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4104","BK4585","NDAQ","BGLC","LU2210149790.SGD","BK4112"],"gpt_icon":0},{"id":"2489198092","title":"BioNexus Gene Lab Leads Our Top 3 US Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2489198092","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489198092?lang=en_us&edition=full_marsco","pubTime":"2024-12-07 04:07","pubTimestamp":1733515673,"startTime":"0","endTime":"0","summary":"The U.S. stock market has been on a notable upswing, with the S&P 500 and Nasdaq reaching record highs following positive employment data that bolstered confidence in economic strength. For investors exploring beyond the well-known giants, penny stocks—typically smaller or newer companies—can offer intriguing opportunities despite their somewhat antiquated name. These stocks can provide surprising value when based on solid financials, and we will explore three examples that showcase potential...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-bglc/bionexus-gene-lab/news/bionexus-gene-lab-leads-our-top-3-us-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4161","BK4209","BK4526","RLX","BK4104","BK4213","BK4563","BK4233","BABB","BK4551","NEPH","BK4205","BK4191","RFL","BGLC","BK4075","PVL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bionexusgenelab.com","stockEarnings":[{"period":"1week","weight":0.0115},{"period":"1month","weight":-0.2873},{"period":"3month","weight":-0.2332},{"period":"6month","weight":-0.3723},{"period":"1year","weight":-0.5825},{"period":"ytd","weight":-0.0597}],"compareEarnings":[{"period":"1week","weight":-0.115},{"period":"1month","weight":-0.1379},{"period":"3month","weight":-0.1578},{"period":"6month","weight":-0.1383},{"period":"1year","weight":-0.0429},{"period":"ytd","weight":-0.1529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.032056},{"month":2,"riseRate":0.4,"avgChangeRate":-0.079222},{"month":3,"riseRate":0.4,"avgChangeRate":-0.0169},{"month":4,"riseRate":0.2,"avgChangeRate":-0.098861},{"month":5,"riseRate":0,"avgChangeRate":-0.277577},{"month":6,"riseRate":0.25,"avgChangeRate":-0.049219},{"month":7,"riseRate":0.5,"avgChangeRate":-0.074891},{"month":8,"riseRate":0.5,"avgChangeRate":0.045138},{"month":9,"riseRate":0.25,"avgChangeRate":-0.192652},{"month":10,"riseRate":0.4,"avgChangeRate":0.104245},{"month":11,"riseRate":0.6,"avgChangeRate":0.187737},{"month":12,"riseRate":0.4,"avgChangeRate":-0.047757}],"exchange":"NASDAQ","name":"BioNexus Gene Lab Corp.","nameEN":"BioNexus Gene Lab Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioNexus Gene Lab Corp.(BGLC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioNexus Gene Lab Corp.(BGLC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioNexus Gene Lab Corp.,BGLC,BioNexus Gene Lab Corp.股票,BioNexus Gene Lab Corp.股票老虎,BioNexus Gene Lab Corp.股票老虎国际,BioNexus Gene Lab Corp.行情,BioNexus Gene Lab Corp.股票行情,BioNexus Gene Lab Corp.股价,BioNexus Gene Lab Corp.股市,BioNexus Gene Lab Corp.股票价格,BioNexus Gene Lab Corp.股票交易,BioNexus Gene Lab Corp.股票购买,BioNexus Gene Lab Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioNexus Gene Lab Corp.(BGLC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioNexus Gene Lab Corp.(BGLC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction